The molecular diagnostics market achieved a valuation of USD 13 billion in 2022 and is projected to reach USD 39.05 billion by 2032, with a compound annual growth rate (CAGR) of 13% throughout the forecast period. Key factors driving this revenue growth include the increased prevalence of infectious diseases and cancer, rising demand for personalized medication, and advancements in molecular...